Abstract
99mTc-mercaptoacetyltriglycine (MAG3) is a new renal radiopharmaceutical which has been shown to have biological properties similar to131I-hippurate (OIH) in animals and volunteers.99mTc-MAG3 has now been compared with131I-orthoiodohippurate (OIH) in a group of patients with varying degrees of renal impairment. In all cases, the99mTc-MAG3 images were superior regardless of serum creatinine. Selected examples are illustrated including scans and renogram curves in a normal volunteer, transplant patients with creatinines of 9.8 mg/dl and 2.6 mg/dl respectively, and a furosemide study in a patient with questionable obstruction. Our preliminary results suggest that99mTc-MAG3 performs well in patients with impaired renal function and may well provide an acceptable replacement for OIH. A kit formulation has been developed and will soon be undergoing clinical evaluation.
Similar content being viewed by others
References
Barbour GL, Crumm CK, Boyd CM, (1976) Comparison of inulin, iothalamate, and99mtechnetium DTPA for measurement of glomerular filtration rate. J Nucl Med 17:317–320
Blaufox MD, Potchen EJ, Merrill JP (1967) Measurement of effective renal plasma flow in man by external counting methods. J Nucl Med 8:77–85
Chervu RL, Sundoro BM, Blaufox MD (1984) Technetium-99m labeled p-aminohippuric acid analog: a new renal agent: Concise communication. J Nucl Med 25:1111–1115
Davison A, Jones A, Orvig C, Sohn M (1981) A new class of oxotechnetium (+5) chelate complexes containing a TcON2S2 core. Inorg Chem 20:1629–1632
Fritzberg AR, Kasina S, Eshima D (1986) Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med 27:111–116
Fritzberg AR, Klingensmith WS, Whitney WP, Kuni CC (1981) Chemical and biological studies of Tc-99m N, N′-bis(mercaptoacetamido)-ethylenediamine: A potential replacement for I-131 hippuran. J Nucl Med 22:258–263
Fritzberg AR, Kuni CC, Klingensmith WC, (1982) Synthesis and biological evaluation of Tc-99m N, N′-bis(mercaptoacetyl)-2,3-diaminopropanoate A potential replacement for (I-131)-o-iodohippurate. J Nucl Med 23:592–598
Klingensmith WC, Fritzberg AR, Spitzer VM, (1983) Clinical evaluation of Tc-99m N,N′-bis(mercaptoacetyl)-2 3-diaminopropanoate as a replacement for I-131 hippuran. J Nucl Med 24: P 80
Klingensmith WC III, Gerhold JP, Fritzberg AR, (1982) Clinical comparison of TC-99m N,N′-bis(mercaptoacetamido)-ethyl-enediamine and [131I] ortho-iodohippurate for evaluation of renal tubular function: Concise communication. J Nucl Med 23:377–380
Klopper JF, Hauser W, Atkins HL, (1972) Evaluation of99mTc-DTPA for the measurement of glomerular filtration rate. J Nucl Med 8:77–85
Marcus CS, Kuperus JH (1985) Pediatric Renal I-123 Orthoiodo-hippurate dosimetry. J Nucl Med 26:1211–1214
McAfee JG, Grossman ZD, Gagne GR, (1981) Comparison of renal extraction efficiencies for radioactive agents in the normal dog. J Nucl Med 22:333–338
Sapirstein LA, Vidt D, Mandel M (1955) Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol 181:330
Stadalnik RC, Vogel JM, Jansholt A-L, Krohn KA, Matolo NM, Lagunas-Solar MC, Zielinski FW (1980) Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH (I-131) and PAH. J Nucl Med 21:168–170
Taylor AT (1980) Quantitative renal function scanning: A historical and current status report on renal radiopharmaceuticals. In: Freeman LM, Weissman HS (eds) Nuclear Medicine Annual 1980. Raven Press, New York, pp 303–340
Taylor A, Eshima D, Christian PC (1986a) Comparison of Tc-99m mercaptoacetyltriglycine (MAG3) and OIH in normal subjects and patients. J Nucl Med 27:962 (abstr)
Taylor A, Eshima D, Fritzberg AR, (1986b) Comparison of I-131 OIH and Tc-99m MAG3 renal imaging in volunteers. J Nucl Med 27:795–803
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, A., Eshima, D. & Alazraki, N. 99mTc-MAG3, a new renal imaging agent: Preliminary results in patients. Eur J Nucl Med 12, 510–514 (1987). https://doi.org/10.1007/BF00620476
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00620476